We advised the joint book-running managers and underwriters on the equity offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million public offering of 940,860 shares of common stock by Heska Corporation. The common stock is listed on the Nasdaq Global Select Market under the symbol “HSKA.”

Heska Corporation sells veterinary and animal health diagnostic and specialty products, including Point of Care diagnostic laboratory instruments and consumables, digital diagnostic imaging instruments, digital cytology services, vaccines, local and cloud-based data services, allergy testing and immunotherapy and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Its core focus is on supporting veterinarians in the canine and feline healthcare space.

The Davis Polk corporate team included partner Alan F. Denenberg and associate Dongbiao Shen. Counsel Kiara L. Rankin and associate Tomislava Dragicevic provided tax advice. Counsel Daniel F. Forester and associate S. Dream Montgomery provided intellectual property advice. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post